Financial Ratios

KMS MEDISURGI LTD.

NSE : NABSE : 540468ISIN CODE : INE870V01014Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE125.000 (0 %)
PREV CLOSE ( ) 125.00
OPEN PRICE ( ) 125.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4000
TODAY'S LOW / HIGH ( )125.00 125.00
52 WK LOW / HIGH ( ) 66.84125
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.740.650.370.340.37
   CEPS(Rs)2.701.531.381.571.67
   DPS(Rs)0.050.050.050.050.05
   Book NAV/Share(Rs)21.8920.2119.5619.2318.95
   Tax Rate(%)13.0024.5448.2138.3840.45
Margin Ratios
   Core EBITDA Margin(%)8.965.476.736.403.08
   EBIT Margin(%)6.223.143.602.453.02
   Pre Tax Margin(%)5.972.763.161.762.10
   PAT Margin (%)5.202.091.641.091.25
   Cash Profit Margin (%)8.074.916.055.005.58
Performance Ratios
   ROA(%)5.892.251.331.141.19
   ROE(%)8.253.281.921.781.99
   ROCE(%)8.654.283.623.423.86
   Asset Turnover(x)1.131.080.811.050.95
   Sales/Fixed Asset(x)1.971.981.482.082.06
   Working Capital/Sales(x)1.771.701.291.831.90
Efficiency Ratios
   Fixed Capital/Sales(x)0.510.510.680.480.48
   Receivable days216.47226.80286.10186.08180.21
   Inventory Days31.2128.8849.0255.7657.56
   Payable days78.5891.39104.27103.19113.74
Valuation Parameters
   PER(x)0.0052.8391.5796.9280.88
   PCE(x)0.0022.4524.7821.0418.12
   Price/Book(x)0.001.701.741.721.59
   Yield(%)0.150.150.150.17
   EV/Net Sales(x)0.371.161.551.131.01
   EV/Core EBITDA(x)4.0819.4319.3917.7713.68
   EV/EBIT(x)5.9736.8843.1246.1933.29
   EV/CE(x)0.501.561.561.571.34
   M Cap / Sales0.001.101.501.051.01
Growth Ratio
   Net Sales Growth(%)6.8937.38-27.404.9434.59
   Core EBITDA Growth(%)63.102.28-8.63-9.14-12.04
   EBIT Growth(%)111.7219.836.77-14.95-19.95
   PAT Growth(%)166.2275.109.36-8.8028.70
   EPS Growth(%)166.2275.119.37-8.8128.69
Financial Stability Ratios
   Total Debt/Equity(x)0.140.150.160.170.18
   Current Ratio(x)5.133.794.144.412.64
   Quick Ratio(x)4.523.353.783.592.07
   Interest Cover(x)24.608.318.143.573.27
   Total Debt/Mcap(x)0.090.090.100.11

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.